Avalo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	1.92	18.05	5.4	6.7	6.75	7.03	27.81	1.15	0	0	Upgrade
Revenue Growth (YoY)	-89.34%	234.40%	-19.42%	-0.76%	-3.96%	-74.73%	2312.27%	-	-	-	Upgrade
Cost of Revenue	1.28	3.43	1.49	0.3	-0.57	3.26	0.64	0	0	0	Upgrade
Gross Profit	0.64	14.62	3.91	6.4	7.32	3.77	27.18	1.15	0	0	Upgrade
Selling, General & Admin	10.3	20.71	24.66	19.76	11.61	11.06	8.51	7.08	4.42	4.88	Upgrade
Research & Development	13.78	31.31	59.84	32.19	11.76	5.79	4.37	10.15	6.59	12.24	Upgrade
Other Operating Expenses	3.91	0.04	1.55	27.29	1.34	22.41	0.4	0	0	0	Upgrade
Operating Expenses	27.99	52.06	86.04	79.24	24.71	39.26	13.29	17.23	11.01	17.12	Upgrade
Operating Income	-27.35	-37.44	-82.13	-72.84	-17.39	-35.49	13.89	-16.08	-11.01	-17.12	Upgrade
Interest Expense / Income	3.42	4.17	2.39	-0.05	0	0	0.02	0.46	0.79	1.21	Upgrade
Other Expense / Income	0.76	0.02	0.05	-6.5	-1.6	4.61	4.13	-0.07	-1.31	-14.8	Upgrade
Pretax Income	-31.53	-41.63	-84.57	-66.29	-15.79	-40.1	9.74	-16.47	-10.49	-3.52	Upgrade
Income Tax	0.01	0.03	-0.2	-2.79	0.28	-0.05	1.97	0	0	0	Upgrade
Net Income	-31.54	-41.66	-84.38	-63.5	-16.07	-40.05	7.77	-16.47	-10.49	-3.52	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	-	-	-	-	-	0	0	0	0	0	Upgrade
Shares Change	1943.58%	0.58%	49.94%	69.83%	26.84%	85.41%	112.39%	296.64%	246.64%	1.36%	Upgrade
EPS (Basic)	-114.00	-1063.00	-2388.00	-2476.81	-806.40	-3456.01	1209.61	-5385.62	-13564.85	-15782.46	Upgrade
EPS (Diluted)	-114.00	-1063.00	-2388.00	-2476.81	-806.40	-3456.01	1209.61	-5385.62	-13564.85	-15782.46	Upgrade
Free Cash Flow	-30.81	-26.85	-71.01	-40.6	-19.4	-3.69	12.56	-14.61	-10.18	-15.54	Upgrade
Free Cash Flow Per Share	-38.44	-684.40	-1820.68	-1560.99	-1266.51	-305.82	1964.14	-4764.37	-13175.15	-69697.09	Upgrade
Gross Margin	33.26%	80.98%	72.38%	95.52%	108.39%	53.61%	97.71%	100.00%	-	-	Upgrade
Operating Margin	-1421.57%	-207.41%	-1521.56%	-1087.37%	-257.67%	-504.94%	49.94%	-1394.64%	-	-	Upgrade
Profit Margin	-1639.50%	-230.78%	-1563.10%	-947.90%	-238.10%	-569.87%	27.94%	-1428.60%	-	-	Upgrade
Free Cash Flow Margin	-1601.51%	-148.72%	-1315.39%	-606.09%	-287.34%	-52.54%	45.14%	-1266.97%	-	-	Upgrade
Effective Tax Rate	-	-	-	-	-	-	20.19%	-	-	-	Upgrade
EBITDA	-27.96	-37.29	-80.52	-64.5	-11.91	-35.55	10.19	-15.98	-9.67	-2.29	Upgrade
EBITDA Margin	-1452.96%	-206.60%	-1491.74%	-962.82%	-176.42%	-505.77%	36.63%	-1386.01%	-	-	Upgrade
Depreciation & Amortization	0.16	0.17	1.66	1.84	3.88	4.55	0.43	0.03	0.02	0.03	Upgrade
EBIT	-28.11	-37.46	-82.18	-66.34	-15.79	-40.1	9.76	-16.01	-9.7	-2.31	Upgrade
EBIT Margin	-1461.17%	-207.52%	-1522.43%	-990.33%	-233.95%	-570.58%	35.10%	-1388.34%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).